Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer
Status:
Active, not recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
This phase III trial studies how well dexamethasone works in reducing everolimus-induced oral
stomatitis in patients with cancer. Dexamethasone may help to reduce the everolimus-induced
oral stomatitis so as to improve quality of life in cancer patients.